Table 4 Percentages of EE and DL of HA-coated 5-FU in ThCs-NPs.

From: Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer

Absorbance

Encapsulation efficiency (EE%)

Encapsulation efficiency % (mean ± SD)

Drug loading (DL)

Drug loading % (mean ± SD)

2.903

81.35

82.3% ± 0.01

19.32

19.27 ± 0.05

2.818

82.78

20.22

2.781

81.97

18.59